Canada markets closed

Nxera Pharma Co., Ltd. (SOLTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
9.300.00 (0.00%)
At close: 12:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
12,766,000
12,766,000
15,569,000
17,712,000
8,842,000
Cost of Revenue
3,102,000
3,102,000
926,000
933,000
761,000
Gross Profit
9,664,000
9,664,000
14,643,000
16,779,000
8,081,000
Operating Expenses
Research Development
10,075,000
10,075,000
7,454,000
5,931,000
3,793,000
Selling General and Administrative
9,965,000
9,965,000
4,377,000
3,940,000
3,435,000
Total Operating Expenses
19,190,000
19,190,000
11,207,000
13,004,000
7,153,000
Operating Income or Loss
-9,526,000
-9,526,000
3,436,000
3,775,000
928,000
Interest Expense
2,495,000
2,495,000
756,000
3,797,000
578,000
Income Before Tax
-10,680,000
-10,680,000
1,078,000
433,000
1,622,000
Income Tax Expense
-3,487,000
-3,487,000
696,000
-584,000
143,000
Income from Continuing Operations
-7,193,000
-7,193,000
382,000
1,017,000
1,479,000
Net Income
-7,193,000
-7,193,000
382,000
1,017,000
1,479,000
Net Income available to common shareholders
-7,193,000
-7,193,000
382,000
1,017,000
1,479,000
Basic EPS
-52.38
-87.18
4.68
12.53
18.77
Diluted EPS
-52.42
-87.18
4.63
12.40
18.59
Basic Average Shares
75,287
82,517
81,785
81,187
78,796
Diluted Average Shares
75,346
82,517
82,590
82,590
79,559